2007 JASN IMPACT FACTOR 7.111	HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP
advanced	CURRENT ISSUE	ARCHIVES	JASN Express	ONLINE SUBMISSION

This Article Full Text Full Text (PDF) All Versions of this Article: ASN.2005010096v1 16/5/1214    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cunningham, P. N. Articles by Quigg, R. J. Search for Related Content PubMed PubMed Citation Articles by Cunningham, P. N. Articles by Quigg, R. J.

Contrasting Roles of Complement Activation and Its Regulation in Membranous Nephropathy

Section of Nephrology, The University of Chicago, Chicago, Illinois

Address correspondence to: Dr. Richard Quigg, Chief of the Section of Nephrology, The University of Chicago, AMB-S523, MC 5100, 5841 South Maryland Avenue, Chicago, IL 60637. Phone: 773-702-0757; Fax: 773-702-4816; E-mail: rquigg{at}uchicago.edu

Abstract

The complement system is involved in defense against microorganisms, the processing of immune complexes and apoptotic debris, and the development of an appropriate immune response. Along with these physiologic effects, complement activation has the potential to result in tissue pathology. To limit this, various complement regulatory proteins (CRP) are present on host cells, including the glomerular podocyte. Experimental data from the Heymann nephritis (HN) rat model of human membranous nephropathy (MN) have shown that IgG antibodies in subepithelial immune deposits initiate complement activation and C5b-9–mediated damage of the overlying podocyte. Although IgG can activate the classical pathway, there also is evidence that alternative pathway activation occurs in MN, which could occur because of absent, dysfunctional, or inhibited podocyte CRP. Related to this are experimental data in HN showing the presence of antibodies that bind and inhibit podocyte CRP; although such antibodies have not been documented in human MN, a decrease in CR1 quantity on the podocyte has been observed. A s a result of a relative lack of CRP and the exposure of activating complement proteins to tubular cells, alternative complement pathway activation and C5b-9–mediated tubular injury can occur in MN and other proteinuric diseases. Overall, in a disease such as MN, the balance between complement regulation and activation is tipped toward its being activated. Therefore, a number of therapeutic approaches have been developed to counteract this, including recombinant forms of endogenous CRP and complement-inhibitory monoclonal antibodies. There is good reason to be optimistic that approaches to block complement activation will become viable therapy for human MN in the future.

This article has been cited by other articles:

				C.-C. Wu, K.-C. Lu, J.-S. Chen, H.-Y. Hsieh, S.-H. Lin, P. Chu, J.-Y. Wang, H.-K. Sytwu, and Y.-F. Lin HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects Nephrol. Dial. Transplant., October 1, 2008; 23(10): 3082 - 3090. [Abstract] [Full Text] [PDF]

				C.-C. Wu, J.-S. Chen, S.-H. Lin, A. Chen, H.-K. Sytwu, and Y.-F. Lin Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events Lab Anim, July 1, 2008; 42(3): 350 - 359. [Abstract] [Full Text] [PDF]

				B. Sherry, W. W. Dai, M. L. Lesser, and H. Trachtman Dysregulated Chemokine Receptor Expression and Chemokine-Mediated Cell Trafficking in Pediatric Patients with ESRD Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 397 - 406. [Abstract] [Full Text] [PDF]

				P. Ronco and H. Debiec Molecular Dissection of Target Antigens and Nephritogenic Antibodies in Membranous Nephropathy: Towards Epitope-Driven Therapies J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1772 - 1774. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673